We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Pharma Home JPG

Pharmaceuticals

  • Pharmaceuticals
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
All you could possibly want to know about the pharmaceutical industry is just a click away.
Home » Topics » Pharmaceuticals
  • July 5, 2022

    AstraZeneca’s Evusheld and Regeneron’s REGEN-COV Shelf Life Extended

    REGEN-COV doses are being stored for possible use against future COVID-19 variants.
  • July 5, 2022

    Sirana Enters Research Collaboration Agreement With Pfizer Over Bone Disease

    The financial terms of the collaboration were not disclosed.
  • July 5, 2022

    FDA Review of Santhera’s Vamorolone NDA Delayed Due to Manufacturing Standards

    The FDA has granted vamorolone Orphan Drug status, as well as Fast Track and Rare Pediatric Disease designations.
Read More

Research and Development

  • June 29, 2022

    Uveitis Prompts Partial Clinical Hold on Nuvation Bio Cancer Drug

  • June 28, 2022

    Federal Judge Lets Stand $6.4 Billion Suit Claiming BMS Stalled New CAR T Cell Therapy

  • June 28, 2022

    GSK’s Hepatitis Drug Candidate Shows Promise

  • June 28, 2022

    Rexulti Shows Efficacy in Reducing Agitation in Alzheimer’s Patients

  • June 27, 2022

    Biogen Ends Post-Marketing Study of Aduhelm Due to Limited National Coverage Policy

Read More

Submissions and Approvals

  • June 30, 2022

    Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

  • June 29, 2022

    EU Expands Approval of Novartis’ Cosentyx for Pediatric Arthritis

  • June 27, 2022

    CHMP Recommends Nine New Drugs in Latest Monthly Meeting

  • June 24, 2022

    Novartis’ Tabrecta Gained EU Approval for Advanced NSCLC

  • June 24, 2022

    FDA Grants Accelerated Approval to Novartis’ Tafinlar and Mekinist Combination

Read More

Products

  • John e lincoln 600green

    Pharmaceutical Process Validation: Best Practices for Success – Webinar Recording/Transcript

    $287.00
  • Scottrburger williamejanssen 500aqua

    Gene & Cell Therapy Regulation: Comparability and Other New Developments – Webinar Recording/Transcript

    $287.00
  • Risks of social media communication 500

    Risks of Social Media Communication: A Guide to FDA and FTC Enforcement

    $397.00
  • Michael m gaba 600red

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does – Webinar Recording/Transcript

    $287.00
More Products

Events

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing